Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208236626> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W3208236626 endingPage "28" @default.
- W3208236626 startingPage "17" @default.
- W3208236626 abstract "In the present work, the main objective was to develop bilayer extended release matrix tablets of etoricoxib by providing a loading dose followed by maintenance dose that expected to improve the therapeutic efficacy of the medication with less toxic effect. As most bilayer tablets are developed as part of a Life Cycle Management Program, the bilayer technology provides a possibility of prolonging patent life of a drug product. Bilayer tablets of etoricoxib was developed successfully with the meticulous proportion of release controlling Hydroxy propyl methyl cellulose K100 (HPMC K100) and lactose. The tablets were prepared by wet granulation technique. Granules for immediate layer and extended layer for different formulations were prepared separately. The formulations were developed and evaluations were performed to examine the parameters that affect the in vitro performance of the tablets. The drug-excipient compatibility was ensured by Fourier transform infrared spectroscopy (FTIR) study. The values of physical parameters of all formulations were found within appreciable limit. Formulation containing HPMC K 100 and lactose in the proportion of 2:1 in the extended release layer was able to release 26.22% of drug in 15 min and shown a steady release of drug for an extended period of 12 h. The dissolution data was put in Korsemeyer–Peppas model in order to find out n value, which describes the drug release mechanism. The n-value of different formulations were found to be variable. The Fourier transform infrared spectroscopy (FTIR) study revealed absence of any other new peaks and also no differences in the positions of the absorption bands in the bilayer tablet F8 that indicate the lack of significant interactions between etoricoxib and other excipients. It had been concluded that once daily immediate-and extended release bilayer tablet of etoricoxib can be formulated with profound physical characteristics and dissolution properties. This resulted in reducing the daily dose and thus minimise the cardiovascular toxicity of etoricoxib." @default.
- W3208236626 created "2021-11-08" @default.
- W3208236626 creator A5042765921 @default.
- W3208236626 creator A5050010289 @default.
- W3208236626 date "2021-10-27" @default.
- W3208236626 modified "2023-09-24" @default.
- W3208236626 title "Detailed Study on the Effect of Pharmaceutical Excipients on the Release Kinetics of Bilayer Tablet" @default.
- W3208236626 doi "https://doi.org/10.9734/bpi/caprd/v3/10109d" @default.
- W3208236626 hasPublicationYear "2021" @default.
- W3208236626 type Work @default.
- W3208236626 sameAs 3208236626 @default.
- W3208236626 citedByCount "0" @default.
- W3208236626 crossrefType "book-chapter" @default.
- W3208236626 hasAuthorship W3208236626A5042765921 @default.
- W3208236626 hasAuthorship W3208236626A5050010289 @default.
- W3208236626 hasConcept C127413603 @default.
- W3208236626 hasConcept C136229726 @default.
- W3208236626 hasConcept C160892712 @default.
- W3208236626 hasConcept C178790620 @default.
- W3208236626 hasConcept C185592680 @default.
- W3208236626 hasConcept C192157962 @default.
- W3208236626 hasConcept C192562407 @default.
- W3208236626 hasConcept C2776214540 @default.
- W3208236626 hasConcept C3019981671 @default.
- W3208236626 hasConcept C41625074 @default.
- W3208236626 hasConcept C42360764 @default.
- W3208236626 hasConcept C43617362 @default.
- W3208236626 hasConcept C55493867 @default.
- W3208236626 hasConcept C71924100 @default.
- W3208236626 hasConcept C88380143 @default.
- W3208236626 hasConceptScore W3208236626C127413603 @default.
- W3208236626 hasConceptScore W3208236626C136229726 @default.
- W3208236626 hasConceptScore W3208236626C160892712 @default.
- W3208236626 hasConceptScore W3208236626C178790620 @default.
- W3208236626 hasConceptScore W3208236626C185592680 @default.
- W3208236626 hasConceptScore W3208236626C192157962 @default.
- W3208236626 hasConceptScore W3208236626C192562407 @default.
- W3208236626 hasConceptScore W3208236626C2776214540 @default.
- W3208236626 hasConceptScore W3208236626C3019981671 @default.
- W3208236626 hasConceptScore W3208236626C41625074 @default.
- W3208236626 hasConceptScore W3208236626C42360764 @default.
- W3208236626 hasConceptScore W3208236626C43617362 @default.
- W3208236626 hasConceptScore W3208236626C55493867 @default.
- W3208236626 hasConceptScore W3208236626C71924100 @default.
- W3208236626 hasConceptScore W3208236626C88380143 @default.
- W3208236626 hasLocation W32082366261 @default.
- W3208236626 hasOpenAccess W3208236626 @default.
- W3208236626 hasPrimaryLocation W32082366261 @default.
- W3208236626 hasRelatedWork W2161165509 @default.
- W3208236626 hasRelatedWork W2167480134 @default.
- W3208236626 hasRelatedWork W2186641987 @default.
- W3208236626 hasRelatedWork W2381828742 @default.
- W3208236626 hasRelatedWork W2748952813 @default.
- W3208236626 hasRelatedWork W2899084033 @default.
- W3208236626 hasRelatedWork W2972507338 @default.
- W3208236626 hasRelatedWork W3208236626 @default.
- W3208236626 hasRelatedWork W4281920447 @default.
- W3208236626 hasRelatedWork W3150410751 @default.
- W3208236626 isParatext "false" @default.
- W3208236626 isRetracted "false" @default.
- W3208236626 magId "3208236626" @default.
- W3208236626 workType "book-chapter" @default.